Tessa L Holyoake

Tessa L Holyoake

Professor of Experimental Haematology, Institute of Cancer Sciences, University of Glasgow
Email verificata su glasgow.ac.uk
Citato da 33740
CML stem cell biology
Andrew C. W. Zannettino

Andrew CW Zannettino

University of Adelaide
Email verificata su adelaide.edu.au
Citato da 22518
haematology myeloma mesenchymal stem cells cml all
Steve O'Brien

Steve O'Brien

Professor of Haematology
Email verificata su steve7233.org
Citato da 11755
CML
Jeroen Janssen

Jeroen Janssen

assistant-professor, Dept of Hematology, Cancer Center Amsterdam, Amsterdam University …
Email verificata su amsterdamumc.nl
Citato da 8607
Hematology AML CML
Juan Carlos Hernandez-Boluda

Juan Carlos Hernandez-Boluda

Hematology Department, Hospital Clínico Universitario de Valencia, Spain
Citato da 7293
MPN CML
David Ross

David Ross

SAHMRI and Centre for Cancer Biology
Email verificata su sa.gov.au
Citato da 6896
CML MPN myeloid neoplasia
David Yeung

David Yeung

Precision Medicine, SAHMRI, Adelaide
Email verificata su adelaide.edu.au
Citato da 4447
CML ALL BMT
Athina Giannoudis

Athina Giannoudis

Dr, University of Liverpool
Email verificata su liverpool.ac.uk
Citato da 4429
Breast Cancer Pharmacogenetics Drug transporters Molecular biology CML
Heather G Jørgensen

Heather G Jørgensen

Senior Research Fellow, Institute of Cancer Sciences, University of Glasgow
Email verificata su glasgow.ac.uk
Citato da 4088
Myeloid malignancy stem cells CML nanoparticles
S.Tiong Ong

S.Tiong Ong

Duke-NUS Medical School
Email verificata su duke-nus.edu.sg
Citato da 3540
Targeted therapies drug resistance biomarkers genomics CML
1 - 10